Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia

被引：14
|
作者：
Zhang, Keyuan [1 ]
Zhang, Xiang [1 ]
Xu, Yang [1 ,2 ,3 ]
Xue, Shengli [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Tang, Xiaowen [1 ,2 ,3 ]
Han, Yue [1 ,2 ,3 ]
Chen, Suning [1 ,2 ,3 ]
Sun, Aining [1 ,2 ]
Zhang, Yanming [4 ,5 ]
Wu, Depei [1 ,2 ,3 ,6 ]
Wang, Ying [1 ,2 ,3 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Minist Hlth, Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China
[4] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Hematol, Dept Neurosurg, 62 Huaihai Rd S, Huaian, Peoples R China
[5] Second Peoples Hosp Huaian, 62 Huaihai Rd S, Huaian, Peoples R China
[6] Soochow Univ, State Key Lab Radiat Med & Protect, Suzhou, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1038/s41408-023-00928-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Keyuan Zhang
    Xiang Zhang
    Yang Xu
    Shengli Xue
    Huiying Qiu
    Xiaowen Tang
    Yue Han
    Suning Chen
    Aining Sun
    Yanming Zhang
    Depei Wu
    Ying Wang
    Blood Cancer Journal, 13
  • [2] Efficacy of hypomethylating agents and Venetoclax in unfit patients with acute myeloid leukemia
    Rieger, M.
    Manz, M. G.
    Muller, R.
    Theocharides, A. P. A.
    Schwotzer, R.
    SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
  • [3] Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
    Shen, Jingyi
    Shan, Meng
    Chu, Mengqian
    Cai, Yiming
    Rui, Jingwen
    Chen, Suning
    Wu, Depei
    Xu, Yang
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [4] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Brian A. Jonas
    Daniel A. Pollyea
    Leukemia, 2019, 33 : 2795 - 2804
  • [5] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Jonas, Brian A.
    Pollyea, Daniel A.
    LEUKEMIA, 2019, 33 (12) : 2795 - 2804
  • [6] Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients
    LeBlanc, Francis R.
    Breese, Erin H.
    Burns, Karen C.
    Chang, Ellen K.
    Jones, LaQuita M.
    Lee, Lynn
    Mizukawa, Benjamin
    Norris, Robin E.
    O'Brien, Maureen M.
    Phillips, Christine L.
    Perentesis, John P.
    Rubinstein, Jeremy
    Pommert, Lauren
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 1055 - 1066
  • [7] Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
    Liang, Peiqi
    Xie, Yan
    Liu, Ziyi
    Wang, Dong
    Li, Qian
    Lu, Yin
    Xue, Shengli
    Wang, Ying
    Chen, Suning
    Wu, Deipei
    Fu, Jianhong
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1219 - 1226
  • [8] Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    DiNardo, Courtney D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 82 - 83
  • [9] Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
    Dian Jin
    Haoguang Chen
    Jingsong He
    Yi Li
    Gaofeng Zheng
    Yang Yang
    Yi Zhao
    Jing Le
    Wenxiu Shu
    Donghua He
    Zhen Cai
    Targeted Oncology, 2024, 19 : 237 - 249
  • [10] Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
    Jin, Dian
    Chen, Haoguang
    He, Jingsong
    Li, Yi
    Zheng, Gaofeng
    Yang, Yang
    Zhao, Yi
    Le, Jing
    Shu, Wenxiu
    He, Donghua
    Cai, Zhen
    TARGETED ONCOLOGY, 2024, 19 (02) : 237 - 249
12345